Showing results 1 to 20 of 22
next >
| Issue Date | Title | Author(s) |
| 2020 | Altered resting-state dynamic functional brain networks in major depressive disorder: Findings from the REST-meta-MDD consortium | Long, Yicheng; Cao, Hengyi; Yan, Chaogan; Chen, Xiao; Li, Le; Castellanos, Francisco Xavier; Bai, Tongjian; Bo, Qijing; Chen, Guanmao; Chen, Ningxuan; Chen, Wei; Cheng, Chang; Cheng, Yuqi; Cui, Xilong; Duan, Jia; Fang, Yiru; Gong, Qiyong; Guo, Wenbin; Hou, Zhenghua; Hu, Lan; Kuang, Li; Li, Feng; Li, Kaiming; Li, Tao; Liu, Yansong; Luo, Qinghua; Meng, Huaqing; Peng, Daihui; Qiu, Haitang; Qiu, Jiang; Shen, Yuedi; Shi, Yushu; Si, Tianmei; Wang, Chuanyue; Wang, Fei; Wang, Kai; Wang, Li; Wang, Xiang; Wang, Ying; Wu, Xiaoping; Wu, Xinran; Xie, Chunming; Xie, Guangrong; Xie, Haiyan; Xie, Peng; Xu, Xiufeng; Yang, Hong; Yang, Jian; Yao, Jiashu; Yao, Shuqiao; Yin, Yingying; Yuan, Yonggui; Zhang, Aixia; Zhang, Hong; Zhang, Kerang; Zhang, Lei; Zhang, Zhijun; Zhou, Rubai; Zhou, Yiting; Zhu, Junjuan; Zou, Chaojie; Zang, Yufeng; Zhao, Jingping; Chan, Calais Kin-yuen; Pu, Weidan; Liu, Zhening |
| 2020 | Biomarkers for Prediction of Schizophrenia: Insights From Resting-State EEG Microstates | Luo, Yu; Tian, Qing; Wang, Changming; Zhang, Ke; Wang, Chuanyue; Zhang, Jicong |
| 2017 | Cognitive dysfunction correlates with elevated serum S100B concentration in drug-free acutely relapsed patients with schizophrenia | Chen, Song; Tian, Li; Chen, Nan; Xiu, Meihong; Wang, Zhiren; Yang, Guigang; Wang, Chuanyue; Yang, Fude; Tan, Yunlong |
| 2015 | Comparative study of the efficacy and safety between blonanserin and risperidone for the treatment of schizophrenia in Chinese patients: A double-blind, parallel-group multicenter randomized trial | Li, Huafang; Yao, Chen; Shi, Jianguo; Yang, Fude; Qi, Shuguang; Wang, Lili; Zhang, Honggeng; Li, Jie; Wang, Chuanyue; Wang, Chuansheng; Liu, Cui; Li, Lehua; Wang, Qiang; Li, Keqing; Luo, Xiaoyan; Gu, Niufan |
| 2015 | Detection of Circulating miRNA Levels in Schizophrenia | Wei, Hui; Yuan, Yanbo; Liu, Sha; Wang, Cheng; Yang, Fude; Lu, Zheng; Wang, Chuanyue; Deng, Hong; Zhao, Jinping; Shen, Yan; Zhang, Chenyu; Yu, Xin; Xu, Qi |
| 2024 | Different levels of prepulse inhibition among patients with first-episode schizophrenia, bipolar disorder and major depressive disorder | Sun, Yue; Bo, Qijing; Mao, Zhen; Tian, Qing; Dong, Fang; Li, Liang; Wang, Chuanyue |
| 2006 | The double-blind controlled trial of bupropion and amitriptyline in the treatment of 229 patients with depressive disorders | Wang, Chuanyue; Zhang, Hongyan; Gao, Chengge; Zhang, Xiuping; Cao, Yi |
| 2023 | Early Efficacy of Antipsychotic Medications at Week 2 Predicts Subsequent Responses at Week 6 in a Large-scale Randomized Controlled Trial | Tang, Yiguo; Wu, Yulu; Li, Xiaojing; Hao, QinJian; Deng, Wei; Yue, Weihua; Yan, Hao; Zhang, Yamin; Tan, Liwen; Chen, Qi; Yang, Guigang; Lu, Tianlan; Wang, Lifang; Yang, Fude; Zhang, Fuquan; Yang, Jianli; Li, Keqing; Lv, Luxian; Tan, Qingrong; Zhang, Hongyan; Ma, Xin; Li, Lingjiang; Wang, Chuanyue; Ma, Xiaohong; Zhang, Dai; Yu, Hao; Zhao, Liansheng; Ren, Hongyan; Wang, Yingcheng; Zhang, Guangya; Li, Chuanwei; Du, Xiangdong; Hu, Xun; Li, Tao; Wang, Qiang |
| Sep-2021 | The effect of selective serotonin reuptake inhibitors on cognitive impairment in patients with depression: A prospective, multicenter, observational study | Liu, Lijun; Lv, Xiaozhen; Zhou, Shuzhe; Liu, Qi; Wang, Jing; Tian, Hongjun; Zhang, Kerang; Wei, Jing; Wang, Chuanyue; Chen, Qiaoling; Zhu, Gang; Wang, Xueyi; Zhang, Nan; Huang, Yu; Si, Tianmei; Yu, Xin |
| 2016 | The effectiveness and safety of amisulpride in Chinese patients with schizophrenia: An 8-week, prospective, open-label, multicenter, single-arm study | Liang, Ying; Cao, Changan; Zhu, Cheng; Wang, Chuanyue; Zhang, Congpei; Dong, Fang; Yang, Fude; Deng, Hong; Yu, Jingjie; Tang, Jisheng; Su, Lei; Xin, Limin; Hong, Ling; Gao, Minglong; Tang, Muni; Xie, Shiping; Lu, Shuiping; Liu, Tiebang; Xu, Xiaojin; Wang, Xijin; Li, Xuanzi; Wang, Xueyi; Li, Yi; Zhang, Yong; Chen, Zhiyu; Yu, Xin |
| Jan-2021 | Impaired Sensorimotor Gating Using the Acoustic Prepulse Inhibition Paradigm in Individuals at a Clinical High Risk for Psychosis | Bo, Qijing; Mao, Zhen; Tian, Qing; Yang, Ningbo; Li, Xianbin; Dong, Fang; Zhou, Fuchun; Li, Liang; Wang, Chuanyue |
| 2017 | Individual differences in schizophrenia | Rolls, Edmund T.; Lu, Wenlian; Wan, Lin; Yan, Hao; Wang, Chuanyue; Yang, Fude; Tan, Yunlong; Li, Lingjiang; Yu, Hao; Liddle, Peter F.; Palaniyappan, Lena; Zhang, Dai; Yue, Weihua; Feng, Jianfeng |
| Nov-2020 | Longitudinal trajectory analysis of antipsychotic response in patients with schizophrenia: 6-week, randomised, open-label, multicentre clinical trial | Dai, Minhan; Wu, Yulu; Tang, Yiguo; Yue, Weihua; Yan, Hao; Zhang, Yamin; Tan, Liwen; Deng, Wei; Chen, Qi; Yang, Guigang; Lu, Tianlan; Wang, Lifang; Yang, Fude; Zhang, Fuquan; Yang, Jianli; Li, Keqing; Lv, Luxian; Tan, Qingrong; Zhang, Hongyan; Ma, Xin; Li, Lingjiang; Wang, Chuanyue; Ma, Xiaohong; Zhang, Dai; Yu, Hao; Zhao, Liansheng; Ren, Hongyan; Wang, Yingcheng; Hu, Xun; Zhang, Guangya; Du, Xiaodong; Wang, Qiang; Li, Tao |
| 2012 | Masking of speech in people with first-episode schizophrenia and people with chronic schizophrenia | Wu, Chao; Cao, Shuyang; Zhou, Fuchun; Wang, Chuanyue; Wu, Xihong; Li, Liang |
| May-2020 | Metabolic Effects of 7 Antipsychotics on Patients With Schizophrenia: A Short-Term, Randomized, Open-Label, Multicenter, Pharmacologic Trial | Zhang, Yamin; Wang, Qiang; Reynolds, Gavin P.; Yue, Weihua; Deng, Wei; Yan, Hao; Tan, Liwen; Wang, Chuanyue; Yang, Guigang; Lu, Tianlan; Wang, Lifang; Zhang, Fuquan; Yang, Jianli; Li, Keqing; Lv, Luxian; Tan, Qingrong; Li, Yinfei; Yu, Hua; Zhang, Hongyan; Ma, Xin; Yang, Fude; Li, Lingjiang; Chen, Qi; Wei, Wei; Zhao, Liansheng; Wang, Huiyao; Li, Xiaojing; Guo, Wanjun; Hu, Xun; Tian, Yang; Ren, Hongyan; Ma, Xiaohong; Coid, Jeremy; Zhang, Dai; Li, Tao |
| 2019 | An open-label randomised comparison of aripiprazole, olanzapine and risperidone for the acute treatment of first-episode schizophrenia: Eight-week outcomes | Cheng, Zhang; Yuan, Yanbo; Han, Xue; Yang, Lei; Cai, Shangli; Yang, Fude; Lu, Zheng; Wang, Chuanyue; Deng, Hong; Zhao, Jingping; Xiang, Yutao; Correll, Christoph U.; Yu, Xin |
| 2016 | Population pharmacokinetic-pharmacodynamic (PopPK/PD) modeling of risperidone and its active metabolite in Chinese schizophrenia patients | Ji, Shuangmin; Shang, Dewei; Wu, Kehua; Li, Anning; Li, Xiwei; Deng, Chenhui; Li, Liang; Zhou, Tianyan; Wang, Chuanyue; Lu, Wei |
| Apr-2023 | Prepulse inhibition and attentional modulation in individuals with attenuated psychotic syndrome and at genetically high risk of schizophrenia | Mao, Zhen; Bo, Qijing; Sun, Yue; Li, Weidi; Dong, Fang; Wang, Chuanyue |
| 2024 | The Role of Total White Blood Cell Count in Antipsychotic Treatment for Patients with Schizophrenia | Zhang, Yamin; Tao, Shiwan; Coid, Jeremy; Wei, Wei; Wang, Qiang; Yue, Weihua; Yan, Hao; Tan, Liwen; Chen, Qi; Yang, Guigang; Lu, Tianlan; Wang, Lifang; Zhang, Fuquan; Yang, Jianli; Li, Keqing; Lv, Luxian; Tan, Qingrong; Zhang, Hongyan; Ma, Xin; Yang, Fude; Li, Lingjiang; Wang, Chuanyue; Zhao, Liansheng; Deng, Wei; Guo, Wanjun; Ma, Xiaohong; Zhang, Dai; Li, Tao |
| 2024 | The Role of Total White Blood Cell Count in Antipsychotic Treatment for Patients with Schizophrenia | Zhang, Yamin; Tao, Shiwan; Coid, Jeremy; Wei, Wei; Wang, Qiang; Yue, Weihua; Yan, Hao; Tan, Liwen; Chen, Qi; Yang, Guigang; Lu, Tianlan; Wang, Lifang; Zhang, Fuquan; Yang, Jianli; Li, Keqing; Lv, Luxian; Tan, Qingrong; Zhang, Hongyan; Ma, Xin; Yang, Fude; Li, Lingjiang; Wang, Chuanyue; Zhao, Liansheng; Deng, Wei; Guo, Wanjun; Ma, Xiaohong; Zhang, Dai; Li, Tao |
